A citation-based method for searching scientific literature

Rouven Hoefflin, Adriana Lazarou, Maria Elena Hess, Meike Reiser, Julius Wehrle, Patrick Metzger, Anna Verena Frey, Heiko Becker, Konrad Aumann, Kai Berner, Martin Boeker, Nico Buettner, Christine Dierks, Jesus Duque-Afonso, Michel Eisenblaetter, Thalia Erbes, Ralph Fritsch, Isabell Xiang Ge, Anna-Lena Geißler, Markus Grabbert, Steffen Heeg, Dieter Henrik Heiland, Simone Hettmer, Gian Kayser, Alexander Keller, Anita Kleiber, Alexandra Kutilina, Leman Mehmed, Frank Meiss, Philipp Poxleitner, Justyna Rawluk, Juri Ruf, Henning Schäfer, Florian Scherer, Khalid Shoumariyeh, Andreas Tzschach, Christoph Peters, Tilman Brummer, Martin Werner, Justus Duyster, Silke Lassmann, Cornelius Miething, Melanie Boerries, Anna L Illert, Nikolas von Bubnoff. Cancers (Basel) 2021
Times Cited: 1







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Personalized oncology through integrative high-throughput sequencing: a pilot study.
Sameek Roychowdhury, Matthew K Iyer, Dan R Robinson, Robert J Lonigro, Yi-Mi Wu, Xuhong Cao, Shanker Kalyana-Sundaram, Lee Sam, O Alejandro Balbin, Michael J Quist,[...]. Sci Transl Med 2011
426
100

An overview of precision oncology basket and umbrella trials for clinicians.
Jay J H Park, Grace Hsu, Ellie G Siden, Kristian Thorlund, Edward J Mills. CA Cancer J Clin 2020
22
100

A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT).
J Mateo, D Chakravarty, R Dienstmann, S Jezdic, A Gonzalez-Perez, N Lopez-Bigas, C K Y Ng, P L Bedard, G Tortora, J-Y Douillard,[...]. Ann Oncol 2018
118
100

Genomic basis for RNA alterations in cancer.
Claudia Calabrese, Natalie R Davidson, Deniz Demircioğlu, Nuno A Fonseca, Yao He, André Kahles, Kjong-Van Lehmann, Fenglin Liu, Yuichi Shiraishi, Cameron M Soulette,[...]. Nature 2020
94
100

A New Software Platform to Improve Multidisciplinary Tumor Board Workflows and User Satisfaction: A Pilot Study.
Elizabeth A Krupinski, Merce Comas, Leia Garrote Gallego. J Pathol Inform 2018
8
100

Establishment of a Molecular Tumor Board (MTB) and Uptake of Recommendations in a Community Setting.
Ari VanderWalde, Axel Grothey, Daniel Vaena, Gregory Vidal, Adam ElNaggar, Gabriella Bufalino, Lee Schwartzberg. J Pers Med 2020
4
100

Molecular Tumor Boards in Clinical Practice.
Claudio Luchini, Rita T Lawlor, Michele Milella, Aldo Scarpa. Trends Cancer 2020
12
100

Bioinformatics for precision oncology.
Jochen Singer, Anja Irmisch, Hans-Joachim Ruscheweyh, Franziska Singer, Nora C Toussaint, Mitchell P Levesque, Daniel J Stekhoven, Niko Beerenwinkel. Brief Bioinform 2019
18
100

Breast Cancer Experience of the Molecular Tumor Board at the University of California, San Diego Moores Cancer Center.
Barbara A Parker, Maria Schwaederlé, Michael D Scur, Sarah G Boles, Teresa Helsten, Rupa Subramanian, Richard B Schwab, Razelle Kurzrock. J Oncol Pract 2015
34
100

Molecular Tumor Boards: current practice and future needs.
D L van der Velden, C M L van Herpen, H W M van Laarhoven, E F Smit, H J M Groen, S M Willems, P M Nederlof, M H G Langenberg, E Cuppen, S Sleijfer,[...]. Ann Oncol 2017
48
100

Personalized Clinical Decision Making Through Implementation of a Molecular Tumor Board: A German Single-Center Experience.
Rouven Hoefflin, Anna-Lena Geißler, Ralph Fritsch, Rainer Claus, Julius Wehrle, Patrick Metzger, Meike Reiser, Leman Mehmed, Lisa Fauth, Dieter Henrik Heiland,[...]. JCO Precis Oncol 2018
12
100

Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study.
Dominic G Rothwell, Mahmood Ayub, Natalie Cook, Fiona Thistlethwaite, Louise Carter, Emma Dean, Nigel Smith, Shaun Villa, Joanne Dransfield, Alexandra Clipson,[...]. Nat Med 2019
101
100

Support systems to guide clinical decision-making in precision oncology: The Cancer Core Europe Molecular Tumor Board Portal.
David Tamborero, Rodrigo Dienstmann, Maan Haj Rachid, Jorrit Boekel, Richard Baird, Irene Braña, Luigi De Petris, Jeffrey Yachnin, Christophe Massard, Frans L Opdam,[...]. Nat Med 2020
13
100

Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH).
Keith T Flaherty, Robert J Gray, Alice P Chen, Shuli Li, Lisa M McShane, David Patton, Stanley R Hamilton, P Mickey Williams, A John Iafrate, Jeffrey Sklar,[...]. J Clin Oncol 2020
24
100

Digital Tumor Board Solutions Have Significant Impact on Case Preparation.
Richard D Hammer, Donna Fowler, Lincoln R Sheets, Athanasios Siadimas, Chaohui Guo, Matthew S Prime. JCO Clin Cancer Inform 2020
4
100

Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists.
Lawrence J Jennings, Maria E Arcila, Christopher Corless, Suzanne Kamel-Reid, Ira M Lubin, John Pfeifer, Robyn L Temple-Smolkin, Karl V Voelkerding, Marina N Nikiforova. J Mol Diagn 2017
241
100

SwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinics.
Franziska Singer, Anja Irmisch, Nora C Toussaint, Linda Grob, Jochen Singer, Thomas Thurnherr, Niko Beerenwinkel, Mitchell P Levesque, Reinhard Dummer, Luca Quagliata,[...]. BMC Med Inform Decis Mak 2018
7
100

Precision oncology based on omics data: The NCT Heidelberg experience.
Peter Horak, Barbara Klink, Christoph Heining, Stefan Gröschel, Barbara Hutter, Martina Fröhlich, Sebastian Uhrig, Daniel Hübschmann, Matthias Schlesner, Roland Eils,[...]. Int J Cancer 2017
65
100

The Development and Validation of Clinical Exome-Based Panels Using ExomeSlicer: Considerations and Proof of Concept Using an Epilepsy Panel.
Rojeen Niazi, Michael A Gonzalez, Jorune Balciuniene, Perry Evans, Mahdi Sarmady, Ahmad N Abou Tayoun. J Mol Diagn 2018
10
100

Trust and responsibility in molecular tumour boards.
David Merry, Christoph Schickhardt, Katja Mehlis, Eva C Winkler. Bioethics 2018
2
100

Molecular Tumor Boards: Ethical Issues in the New Era of Data Medicine.
Henri-Corto Stoeklé, Marie-France Mamzer-Bruneel, Charles-Henry Frouart, Christophe Le Tourneau, Pierre Laurent-Puig, Guillaume Vogt, Christian Hervé. Sci Eng Ethics 2018
13
100

Variant classification in precision oncology.
Jonas Leichsenring, Peter Horak, Simon Kreutzfeldt, Christoph Heining, Petros Christopoulos, Anna-Lena Volckmar, Olaf Neumann, Martina Kirchner, Carolin Ploeger, Jan Budczies,[...]. Int J Cancer 2019
22
100

Requirements Analysis and Specification for a Molecular Tumor Board Platform Based on cBioPortal.
Philipp Buechner, Marc Hinderer, Philipp Unberath, Patrick Metzger, Martin Boeker, Till Acker, Florian Haller, Elisabeth Mack, Daniel Nowak, Claudia Paret,[...]. Diagnostics (Basel) 2020
5
100

Genomic Profiling of Blood-Derived Circulating Tumor DNA from Patients with Colorectal Cancer: Implications for Response and Resistance to Targeted Therapeutics.
In Sil Choi, Shumei Kato, Paul T Fanta, Lawrence Leichman, Ryosuke Okamura, Victoria M Raymond, Richard B Lanman, Scott M Lippman, Razelle Kurzrock. Mol Cancer Ther 2019
8
100

Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'.
Benedikt C Westphalen, Carsten Bokemeyer, Reinhard Büttner, Stefan Fröhling, Verena I Gaidzik, Hanno Glimm, Ulrich T Hacker, Volker Heinemann, Anna L Illert, Ulrich Keilholz,[...]. Eur J Cancer 2020
8
100

Standards and Guidelines for the Interpretation and Reporting of Sequence Variants in Cancer: A Joint Consensus Recommendation of the Association for Molecular Pathology, American Society of Clinical Oncology, and College of American Pathologists.
Marilyn M Li, Michael Datto, Eric J Duncavage, Shashikant Kulkarni, Neal I Lindeman, Somak Roy, Apostolia M Tsimberidou, Cindy L Vnencak-Jones, Daynna J Wolff, Anas Younes,[...]. J Mol Diagn 2017
535
100


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.